Frank J. Williams - 18 Jan 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
18 Jan 2022
Net transactions value
-$447,700
Form type
4
Filing time
20 Jan 2022, 16:04:04 UTC
Previous filing
14 Feb 2022
Next filing
18 Feb 2022
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Frank J. Williams filed Form 4 for Evolent Health, Inc. (EVH) on 20 Jan 2022."

Quick Takeaways

  • This page summarizes Frank J. Williams's Form 4 filing for Evolent Health, Inc. (EVH).
  • 4 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 20 Jan 2022, 16:04.

What Changed

  • Previous filing in this sequence was filed on 14 Feb 2022.
  • Current net transaction value: -$447,700.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $38,400 +10,000 +1.7% $3.84* 587,809 18 Jan 2022 Direct F1, F2
transaction EVH Class A Common Stock Sale $243,100 -10,000 -1.7% $24.31 577,809 18 Jan 2022 Direct F1, F2, F3
transaction EVH Class A Common Stock Sale $243,000 -10,000 -1.7% $24.30 567,809 18 Jan 2022 Direct F1, F2, F3
holding EVH Class A Common Stock 66,064 18 Jan 2022 See Footnote. F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -10,000 -1.6% $0.000000 609,060 18 Jan 2022 Class A Common Stock 10,000 $3.84 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2021.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.91 to $25.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
F5 The Class A Common Stock Options exercised vested on December 1, 2014.

Sponsored